Case Study: FAPI PET/CT Identifies Hidden Contralateral DCIS and Supraclavicular Metastasis, Informing Neoadjuvant Treatment in Synchronous Bilateral Breast Cancer - Scorecard - MDSpire

Case Study: FAPI PET/CT Identifies Hidden Contralateral DCIS and Supraclavicular Metastasis, Informing Neoadjuvant Treatment in Synchronous Bilateral Breast Cancer

  • By

  • Lin Cong

  • Bin Ji

  • Yiqi Gu

  • Yilin Wu

  • Wan Wang

  • April 24, 2026

  • 0 min

Share

Clinical Scorecard: Case Study: FAPI PET/CT Identifies Hidden Contralateral DCIS and Supraclavicular Metastasis, Informing Neoadjuvant Treatment in Synchronous Bilateral Breast Cancer

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with synchronous bilateral breast cancer.
Care Setting

Key Highlights

  • FAPI PET/CT identified occult contralateral DCIS and supraclavicular metastasis.
  • Conventional FDG PET/CT missed significant regional spread.
  • Neoadjuvant chemotherapy response monitored via FAPI PET/CT showed complete response.
  • FAPI PET/CT influenced treatment decisions by revealing hidden disease.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider neoadjuvant chemotherapy based on comprehensive staging and the presence of contralateral disease.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Female patients with inflammatory breast cancer and other types of synchronous bilateral involvement.

        Clinical Best Practices

        • Integrate advanced imaging techniques like FAPI PET/CT in staging protocols.
        • Perform biopsies on FAPI-avid lesions to confirm diagnosis.
        • Consider follow-up imaging after treatment to assess long-term outcomes.

        References

        Original Source(s)

        Case Study: FAPI PET/CT Identifies Hidden Contralateral DCIS and Supraclavicular Metastasis, Informing Neoadjuvant Treatment in Synchronous Bilateral Breast Cancer

        • by Lin Cong, Bin Ji, Yiqi Gu, Yilin Wu, Wan Wang

        • April 24, 2026

        Related Content

        Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

        Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

        Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort